Home / Products / Formulations / Svizera Healthcare /Manav Care / Svizunate Inj.
 

SVIZUNATE Inj.:

 
         
       
       
           
           
       
         
         
       
        Composition
         
        Composite pack of SVIZUNATE INJ. Contains:
        Artesunate injection 60 mg
         
         
        Therapeutic Indications & Usage
         
        In Severe Malaria
         
         
        Contraindications
         
        SVIZUNATE INJ. is contraindications to hypersensitivity for Artesunate
         
         
        Precautions & Warnings
         
        Special Precautions in Hepatic or renal insufficiency. Pregnancy and lactation.
         
         
        Adverse Reactions
         
        Adverse Drug Reactions with SVIZUNATE inj.are Transient and reversible reticulocytopaenia, drug fever, rash, bradycardia, transient 1st-degree heart block and reversible elevation of serum transaminases
         
         
        Drug Interaction
         
        Drug Interactions (of SVIZUNATE inj.) Antimalarial potentiating action seen with mefloquine, primaquine and tetracycline.
        Additive effect with chloroquine. Antagonistic effect with pyrimethamine and sulphonamides
         
         
        Recommended Dosage & Administration
         
        Parenteral
        Adult:
        2.4 mg/kg via IM or IV admin. Repeat 12 hr and 24 hr later, then once daily thereafter.
         
        Child:
        2.4 mg/kg via IM or IV admin. Repeat 12 hr and 24 hr later, then once daily thereafter
         
         
        Presentations
         
        SVIZUNATE INJ. pack
         
       
         
       
       
         
       
 

 

"Maneesh" Pharmaceuticals   |  Manufacturing Excellence  |   International Presence  |  Products
"Maneesh" for Doctors  |  Our Team  |  For the Patients  
Contact Us  |  Feedback  |  Site Map  | Search Maneesh